BioXcel Therapeutics, Inc.

BTAI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$29,854$65,221$193,725$232,968
Short-Term Investments$0$0$0$0
Receivables$131$71$248$0
Inventory$679$1,991$1,985$0
Other Curr. Assets$6,730$4,860$6,910$3,844
Total Curr. Assets$37,394$72,143$202,868$236,812
Property Plant & Equip (Net)$857$1,472$2,060$2,541
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$87$87$925$86
Total NC Assets$944$1,559$2,985$2,627
Other Assets$0$0$0$0
Total Assets$38,338$73,702$205,853$239,439
Liabilities
Payables$15,990$13,654$10,228$4,678
Short-Term Debt$374$346$319$293
Tax Payable$91$116$82$302
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,778$13,151$22,269$11,394
Total Curr. Liab.$22,233$27,267$32,898$16,667
LT Debt$102,573$101,038$93,837$1,105
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$6,633$1,905$2,343$0
Total NC Liab.$109,206$102,943$96,180$1,105
Other Liabilities$0$0$0$0
Cap. Leases$439$786$1,105$1,398
Total Liabilities$131,439$130,210$129,078$17,772
Equity
Pref Stock$0$0$0$0
Common Stock$49$30$28$28
Retained Earnings-$650,197-$590,598-$411,545-$245,788
AOCI$0$0$0$0
Other Equity$557,047$534,060$488,292$467,427
Total Equity-$93,101-$56,508$76,775$221,667
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$38,338$73,702$205,853$239,439
Net Debt$73,093$36,163-$99,569-$231,570
BioXcel Therapeutics, Inc. (BTAI) Financial Statements & Key Stats | AlphaPilot